1/9 #TumorBoardTuesday
🔬A discussion on EBV+ #GastricCancer-important differences in tx led by @SunnieSKim

➡️Here's the Thursday Case🎀

👉👉Don’t forget to pick up🆓 #CME by answering 2 quick❓

Here's post-test🔗: bit.ly/3yRO1cb

ALL CME🔗: integrityce.com/tbt
2/9 #TumorBoardTuesday Thursday Case🎀
Take🏠:

#GastricCancer are NOT all the same; ≈10% EBV+

✅EBV+ likely⬆️PD-L1; exclusive w HER2 mut
✅EBV+ responsive to immunotx
✅Should EBV🧪be standard?

📚We captured as much of @SunnieSKim’s chat as we could:

twitter.com/i/events/14332…
3/9 #TumorBoardTuesday Thurs Case🎀
@SunnieSKim tweetorial

✅8-10% of GC =EBV+
✅Methyl of viral/host DNA➡️GC
✅⬆️in👨‍🦰/young pts
✅Diffuse type, lymphoid infiltrate & prox loc
✅🔦: hypoechoic submuc nodule
✅⬆️CD8+ TILs & immune 🧬 (IFN-g)
✅TP53, HER2 changes✖️common in EBV+
4/9 #TumorBoardTuesday Thursday Case🎀 (09/07/2021)

@SunnieSKim presented 💼 of a pt with EBV+ gastric CA (EBER+ ISH);⬆️PD-L1 CPS= 50%

Crowd 💬 FOLFOX+ nivo would be a good 1L strategy.

Recent approval of nivo+chemo upfront based on CheckMate 649✅

pubmed.ncbi.nlm.nih.gov/34102137/
5/9 #TumorBoardTuesday Thursday Case🎀 (09/07/2021)

EBER+ gastric CA tend to have excellent response to IO. Usually PD-L1, but not always...but @FogacciJoao points out a💼 of hyperprog on IO.

ascopubs.org/doi/abs/10.120…

pubmed.ncbi.nlm.nih.gov/30013197/ comprehensive molecular cha...
6/9 #TumorBoardTuesday Thursday Case🎀

❓Looks like EBV+ dz tends to be MSS, & while some dz is assoc w/ increased PD-L1, isn’t always the 💼. EBV driven dz also tends to be HER2-.

➡️🔬@ShimaghavimiMD points out: need more research on interaction w H. pylori, endo, microbiome
7/9 #TumorBoardTuesday Thursday Case🎀

Another wrinkle: EBV+ dz more common in males, but prognosis👎in females. Is there a🔗btwn the microbiome🦠, & endocrine signaling? Is there a relationship btwn immune differences in M vs F?

@NPR 🔗comparing wnycstudios.org/podcasts/radio…
8/9 #TumorBoardTuesday Thursday Case🎀

✅EBV+ gastric ca have diff biology; may be⬆️to IO
✅⬆️common than we think...should we test for EBV? ISH/IHC? Will better🧬supplant?
Time will tell.

@loconte says yes!
Pathologists were🤷‍♀️: @PancPathologist @jansen_marnix @JDekervel
9/9 #TumorBoardTuesday Thursday Case🎀(09/07/21)

Prog dz after 1 year with FOLFOX+ nivolumab
🙏Can dual IO (ipi/nivo) re-sensitize tumor?
🤔More research on EBV driven disease & unique biology needed

➡️Please be sure to join us on 09/28/21 for the next #TumorBoardTuesday case😀
#PostTest Q1️⃣ #CME #TumorBoardTuesday

🤔What percent of gastric cancer is associated with Epstein Barr Virus (EBV)?❓

👉🏽posttest🔗 bit.ly/3yRO1cb

👉🏽ALL CME🔗 integrityce.com/tbt

@SunnieSKim #GastricCancer #StomachCancer #EBV #GITwitter #OncTwitter @MPishvaian
#PostTest Q2️⃣ #CME #TumorBoardTuesday

🤔What is the gold 🥇standard test 🧪to detect EBV associated gastric cancer❓

👉🏽posttest🔗 bit.ly/3yRO1cb

👉🏽ALL CME🔗 integrityce.com/tbt

@SunnieSKim #GastricCancer #StomachCancer #EBV #GITwitter #OncTwitter @MPishvaian

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with #TumorBoardTuesday

#TumorBoardTuesday Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @TumorBoardTues

22 Dec 21
1/ 🌟 Calling #Oncology HCPs 🌟

🆕 #TumorBoardTuesday #Tweetorial
🚨 🧬 HER2 in Breast Cancer
👥 @MPishvaian & @ErikaHamilton9

Supported by educational grants from AstraZeneca Pharmaceuticals & Daiichi Sankyo, Inc.

CME ℹ️ bit.ly/3ecVOcC

🗣️ What's your specialty ⁉️
2/ 🗒️ Full reference list & glossary 👉 bit.ly/3yMvIGW

🔑 Key #CME & faculty info 👇, full info 👉 bit.ly/3ecVOcC

#TumorBoardTuesday
3/ 🛑 POLL 🛑

🤔 In a Ph3 trial, which agent has demonstrated an ORR of nearly 80% ❓
#TumorBoardTuesday
Read 24 tweets
17 Dec 21
1/9 #TumorBoardTuesday #PostTest Q1️⃣ #CME
Case🎀

@doctorC369 took us on a 🛣️through metastatic #GEA. Lots of pearls🦪 here. First: two ❓...then the wrap up!

🤔These biomarkers are actionable in advanced #EsophagoGastricCancer except…

👉🏽Posttest 🔗: bit.ly/3pKtAvs
2/9 #PostTest Q2️⃣ #CME #TumorBoardTuesday
👉🏽posttest🔗: bit.ly/3pKtAvs

ALL🥇CME🔗: integrityce.com/tbt

🤔 Addition of immunotherapy to chemotherapy in the 1st line Rx of advanced #EsophagoGastricCancer significantly improves PFS and OS PDL1 CPS>1%
3/9 #TumorBoardTuesday
Thursday Case🎀- 12.14.2021

Lots of take🏠messages- 2 TWEETS!
We discussed metastatic #GEA
✅Chemo + XRT needed to be used fast when facing obstruction- biomarkers can wait
📣✅REMEMBER- no 5-FU bolus‼️📣
Read 10 tweets
8 Dec 21
1/ 🗣️ #TumorBoardTuesday #Tweetorial

🧠 Prevalence, role, genomic testing 🧬HER family receptors
🥼 @MPishvaian @PancPathologist
Supported by educational grants from AstraZeneca Pharmaceuticals & Daiichii Sankyo, Inc.

🆓 #CME 👉 bit.ly/3Dxuh02

📊 Your specialty👇 ❓
2/ 🗒️ Full reference list & glossary 👉 bit.ly/3rKead3

🔑 Key #CME & faculty info 👇 , full info 👉 bit.ly/3Dxuh02

#TumorBoardTuesday Image
3/ 🧬 HER2 alteration occurs in multiple cancer types

🔎 Breast cancer (BC) ➡️ 25% of cases

🔎 Gastric cancer (GC) ➡️ 22%

🔎 Gastroesophageal junction (GEJxn) cancer ➡️ 32%

🔎 Colorectal cancer (CRC) ➡️ 5%

🔎 Non-small cell lung cancer (NSCLC) ➡️ 6%-30%
#TumorBoardTuesday Image
Read 19 tweets
1 Dec 21
#TBTWebinar w/ @MPishvaian, @PancPathologist, @BreastCancerMD1, & Emanuel Petricoin

#CME🔗 bit.ly/3E7Crgu
Pretest bit.ly/3lkw2r0
Claim credit bit.ly/3ljVVXM

Supported by AstraZeneca Pharmaceuticals & Daiichi Sankyo, Inc.

twitter.com/i/broadcasts/1…
#TumorBoardTuesday
HER2 #TBTWebinar 🔑

HER2 (ERBB2) is frequently altered in cancer
(Breast, Lung, Gastric, Biliary, CRC)

Marked by⬆️expression from🧬amplification

Also⬆️activity due to a🌟constitutively active🧬mutation

🤔1⃣of a few🎯molecular drivers of aggressive cancer Slide labels for alt text: ...
#TumorBoardTuesday
HER2 #TBTWebinar 🧐

➡️HER2 (ERBB2) testing & cut-offs varies between disease types

➡️IHC, FISH/CISH, & NGS can be used

➡️🧐Importantly, even HER2-low expression tumors may still benefit from emerging HER2-targeted antibody-drug conjugates🎯 Slide labels for alt text: ...
Read 7 tweets
12 Nov 21
1/8 #TumorBoardTuesday
➡️This week's Thurs Case🎀 is here!

🔬We discussed locally advanced #PancreaticCancer--& sig of germline muts (ATM). @SirohiBhawna takes us on her pt’s treatment journey.

🗝️insights 🤔on locally advanced #PANCAN below!
#PancreaticCancerAwarenessMonth Image
1.5/8 #TumorBoardTuesday

👉👉 Don’t forget to pick up your 🆓 #CME credit by answering 2 quick❓
Here’s the post-test 🔗: bit.ly/3ws480C

ALL CME 🔗: integrityce.com/tbt Now...on to the case!
2/8 #TumorBoardTuesday
Thurs Case🎀
11/09/2021
Take🏠:

✅Upfront tx depends on pt- mFFX vs gem/nab-pac
✅Test all #PDAC for germline mut regardless of FH!‼️
✅Screen w annual MRI/EUS in gATM
✅Emerging 💊combos tx ATM-mut
#PANCAN req multi-D- role for palliative SBRT, ?IRE
Read 12 tweets
29 Oct 21
1/10 #TumorBoardTuesday
Thursday Case🎀
This week’s case: pt w #GEA not responding to FLOT w dMMR/MSI. Receives 3 doses of pembrolizumab->pCR!

💡Biomarker-based IO can be v successful, but better biomarkers needed‼️
➡️Explore wrap up below re: deploying IO in #UGI Image
2/10 #TumorBoardTuesday

👉👉 Don’t forget to pick up your 🆓 #CME credit by answering 2 quick ❓
Here is the post-test 🔗: bit.ly/3EgtZeE

ALL CME 🔗: integrityce.com/tbt Image
3/10 #TumorBoardTuesday
Thursday Case🎀

Take🏠messages:
We discussed #GastricCancer & immunotherapy (IO)
✅dMMR/MSI quite common- 8-22% of non-metastatic cases
✅Chemo less effective in dMMR disease, particularly 5-FU
✅High pCR with upfront IO
✅ctDNA may be a key biomarker
Read 13 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(